Healthcare
Uniphar acquires Dutch pharmaceutical company for €75m
BModesto focuses on the distribution of medicines, clinical trial services, market authorisation holder and medical device distribution
Uniphar, the Irish-listed healthcare group, has acquired BModesto Group, a Dutch pharmaceutical business, in a deal worth €75 million.
BModesto, which reported EBDITA of €7.7 million in 2021, focuses on the distribution of medicines, clinical trial services, market authorisation holder and medical device distribution.
The Lelystad-based company was founded in 2014 and has a workforce of more than 180 people.
Uniphar on Monday said the company would be integrated into its Product Access division of ...